Meeting News

Sitravatinib plus nivolumab demonstrates early efficacy in advanced NSCLC

September 19, 2017
CHICAGO — The combination of sitravatinib and nivolumab conferred partial responses in a small cohort of patients who previously progressed on…
Meeting NewsVideo

VIDEO: Additional treatment with ALK inhibitor after progression shows promise in non-small cell lung cancer

September 18, 2017
CHICAGO — Ensartinib shows promise for the treatment of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer…
Meeting News

Smoking status does not impact outcomes with anti-PD-1 therapy

September 18, 2017
CHICAGO — Smoking status did not affect biomarkers, immune-related adverse events or survival among patients treated with anti-PD-1 therapy for…
Meeting NewsVideo

VIDEO: Stereotactic ablative radiotherapy, nivolumab trial warrants further investigation

September 17, 2017
CHICAGO — Further investigation is warranted regarding treatment with stereotactic ablative radiotherapy in combination with anti-PD-1 therapy…
Meeting NewsPerspective

Tocilizumab manages adverse events following PD-1 blockade therapy

September 16, 2017
CHICAGO — Tocilizumab appeared to be a viable therapeutic option for patients with lung cancer who experienced an immune-mediated adverse event…
Meeting NewsPerspective

Ensartinib shows promise in ALK-positive lung cancer

September 16, 2017
CHICAGO — Ensartinib appeared safe and effective in patients with anaplastic lymphoma kinase-positive non-small cell lung cancer, according to…
Meeting News

Dabrafenib plus trametinib shows promise over docetaxel for BRAF-mutated NSCLC

September 16, 2017
CHICAGO — Combination therapy with dabrafenib and trametinib conferred longer survival than docetaxel for patients with BRAF V600E-positive…
Meeting News

Smoking cessation counseling successfully integrates into screening program

September 16, 2017
CHICAGO — A majority of heavy smokers enrolled in University of Arkansas’s lung cancer screening program quit or decreased their tobacco…
Meeting News

Smoking cessation counseling successfully integrates into screening program

HemOnc Today, November 10, 2017
CHICAGO — A majority of heavy smokers enrolled in University of Arkansas’s lung cancer screening program quit or decreased their tobacco…
Meeting NewsPerspective

Nintedanib shows promise for malignant pleural mesothelioma

September 16, 2017
CHICAGO — The addition of nintedanib to pemetrexed/cisplatin appeared safe and effective for the treatment of patients with malignant pleural…
Advertisement
Advertisement